Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BAXTER INTERNATIONAL INC.

(BAX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Baxter International : Proposed Hillrom Deal Includes 'Solid' EPS Accretion, UBS Says

09/03/2021 | 03:58pm EDT


ę MT Newswires 2021
All news about BAXTER INTERNATIONAL INC.
10/22BAXTER INTERNATIONAL : and bioMerieux Announce CE Mark for NEPHROCLEAR CCL14 Test to Predi..
AQ
10/22BIOMERIEUX : BioMérieux, Baxter International Receive CE Mark for Acute Kidney Injury Test
MT
10/21BAXTER INTERNATIONAL : Secures CE Mark for Test Predicting Persistent Severe Acute Kidney ..
MT
10/21BAXTER INTERNATIONAL : and bioMérieux Announce CE Mark for NEPHROCLEAR™ CCL14 Test t..
BU
10/18BAXTER INTERNATIONAL : Brainstorming for Business Solutions
PU
10/18BAXTER INTERNATIONAL INC : Regulation FD Disclosure (form 8-K)
AQ
10/13BAXTER INTERNATIONAL : Unlocking a Life of Possibilities with Home Parenteral Nutrition
PU
10/13BAXTER INTERNATIONAL : to Present at Credit Suisse 30th Annual Virtual Healthcare Conferen..
BU
10/13CAMURUS : Appoints New CFO
MT
10/07BAXTER INTERNATIONAL : Expanding Diversity in Healthcare
PU
More news
Analyst Recommendations on BAXTER INTERNATIONAL INC.
More recommendations
Financials (USD)
Sales 2021 12 609 M - -
Net income 2021 1 544 M - -
Net Debt 2021 2 437 M - -
P/E ratio 2021 26,9x
Yield 2021 1,28%
Capitalization 41 088 M 41 088 M -
EV / Sales 2021 3,45x
EV / Sales 2022 3,26x
Nbr of Employees 50 000
Free-Float 73,0%
Chart BAXTER INTERNATIONAL INC.
Duration : Period :
Baxter International Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAXTER INTERNATIONAL INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 16
Last Close Price 82,19 $
Average target price 94,00 $
Spread / Average Target 14,4%
EPS Revisions
Managers and Directors
JosÚ E. Almeida Chairman, President & Chief Executive Officer
James K. Saccaro Chief Financial Officer & Executive Vice President
Sumant Ramachandra Chief Science & Technology Officer, Senior VP
Tobi Karchmer Vice President-Worldwide Medical
Talvis Love Chief Information Officer & Senior Vice President
Sector and Competitors
1st jan.Capi. (M$)
BAXTER INTERNATIONAL INC.2.43%41 088
ABBOTT LABORATORIES15.74%224 651
MEDTRONIC PLC5.08%165 656
BECTON, DICKINSON AND COMPANY-1.25%70 962
HOYA CORPORATION21.65%56 316
DEXCOM, INC.53.24%54 815